Patents by Inventor Cheng Yi Jenny Shu

Cheng Yi Jenny Shu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9151757
    Abstract: The present invention relates to methods for detecting antigen responsive cells in a sample using multidimensional labeled antigen presenting compounds, such as antigen-major histocompatibility complexes (NHC). Further, the present invention relates to the use of the present multidimensional labeled antigen presenting compounds, such as antigen-major histocompatibility complexes (MHC), for detecting antigen responsive cells in a sample, preferably a single sample, such as a blood sample. The present method allows high-throughput analysis of specific antigen responsive cells, such as T- and B-cells, thereby providing, for example, high-throughput methods for monitoring of diseases or conditions and the development of immunotherapeutics, vaccines, or the identification epitopes or immunogenic amino acid sequences.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: October 6, 2015
    Assignees: Stichting Sanquin Bloedvoorziening, Stichting het Nederlands Kanker Instituut
    Inventors: Sine Reker-Hadrup, Arnold Hendrik Bakker, Cheng Yi Jenny Shu, Antonius Nicolaas Maria Schumacher
  • Publication number: 20110269155
    Abstract: The present invention relates to methods for detecting antigen responsive cells in a sample using multidimensional labeled antigen presenting compounds, such as antigen-major histocompatibility complexes (NHC). Further, the present invention relates to the use of the present multidimensional labeled antigen presenting compounds, such as antigen-major histocompatibility complexes (MHC), for detecting antigen responsive cells in a sample, preferably a single sample, such as a blood sample. The present method allows high-throughput analysis of specific antigen responsive cells, such as T- and B-cells, thereby providing, for example, high-throughput methods for monitoring of diseases or conditions and the development of immunotherapeutics, vaccines, or the identification epitopes or immunogenic amino acid sequences.
    Type: Application
    Filed: November 3, 2008
    Publication date: November 3, 2011
    Applicants: STICHTING HET NEDERLANDS KANKER INSTITUUT, STICHTING SANQUIN BLOEDVOORZIENING
    Inventors: Sine Reker-Hadrup, Arnold Hendrik Bakker, Cheng Yi Jenny Shu, Antonius Nicolaas Maria Schumacher